Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.32 |
| ▸ | PRKCG | P05129 | 1/20 | 0.32 |
| ▸ | PRKCB | P05771 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | PRKCH | P24723 | 1/20 | 0.32 |
| ▸ | PRKCI | P41743 | 1/20 | 0.32 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.32 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.32 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.32 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.32 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.32 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.31 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.31 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25980467 | 0.95 | PRKD3 (0.31) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25980491 | 0.93 | CYP1A2 (0.32) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25980481 | 0.93 | CYP1A2 (0.32) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL24098414 | 0.82 | PRKD3 (0.33) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL17916643 | 0.81 | KDM4E (0.34) | — | |
| SCHEMBL25980380 | 0.81 | PRKD3 (0.33) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25980391 | 0.81 | PRKD3 (0.33) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25980367 | 0.79 | PRKD3 (0.32) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL25980346 | 0.77 | LMNA (0.38) | — | |
| SCHEMBL25980249 | 0.76 | CYP1A2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240128-A1 | COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240128-A1 | COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | NONO, EPHA4, EPHA6 | PRKD3 2447/4885PRKCG 1819/4885PRKCB 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.